These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Therapeutic use of digitalis and substances with analogous action. Lecture IV]. Messini M Clin Ter; 1971 Feb; 56(4):307-40. PubMed ID: 5581067 [No Abstract] [Full Text] [Related]
23. [Comparative study of the resorption, distribution, and excretion of digitalis glycosides in experimental animals]. Buchtela K; Drexler K; Fehringer A; Hackl H; Königstein M; Schläger J Wien Z Inn Med; 1970; 51(5):227-35. PubMed ID: 5535605 [No Abstract] [Full Text] [Related]
24. Interactions of digitalis. Milliken JA Can Med Assoc J; 1979 Aug; 121(3):263-4. PubMed ID: 466599 [No Abstract] [Full Text] [Related]
25. [Contribution of serum determinations of digitoxin and digoxin by radioimmunoassay in acute digitalis poisoning]. Ducloux G; Dessaint JP; Warembourg H Lille Med; 1977 Jan; 22(1):56-9. PubMed ID: 846291 [No Abstract] [Full Text] [Related]
26. [Prospective studies with digitalis]. Bodem G Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():76-83. PubMed ID: 612052 [No Abstract] [Full Text] [Related]
28. [Incidence of side effects in digitalis therapy]. Flasch H Fortschr Med; 1982 Oct; 100(38):1743-8. PubMed ID: 7141373 [TBL] [Abstract][Full Text] [Related]
29. Clinical pharmacology of digitalis glycosides. Doherty JE; Kane JJ Annu Rev Med; 1975; 26():159-71. PubMed ID: 1096754 [No Abstract] [Full Text] [Related]
30. [The problem of a formal digitalis dosage]. Schaefer J; van Zwieten PA Dtsch Med Wochenschr; 1973 Jul; 98(28):1377-8. PubMed ID: 4716794 [No Abstract] [Full Text] [Related]
31. Clinical consequences of pharmacokinetic properties of cardiac glycosides. Kochsiek K Eur Heart J; 1982 Dec; 3 Suppl D():79-86. PubMed ID: 6761130 [No Abstract] [Full Text] [Related]
33. Absorption of digitalis compounds. Co ED N Engl J Med; 1971 Oct; 285(16):922. PubMed ID: 5112740 [No Abstract] [Full Text] [Related]
34. Cardiac glycosides: digitalis, digoxin, and digitoxin. Plaut D Am J Med Technol; 1978 Sep; 44(9):896-904. PubMed ID: 707558 [No Abstract] [Full Text] [Related]
35. Digitalis toxicity: drug interactions promoting toxicity and the management of toxicity. Bigger JT; Strauss HC Semin Drug Treat; 1972; 2(2):147-77. PubMed ID: 4404460 [No Abstract] [Full Text] [Related]
36. [Influence of digestive juices on hhe stability of the digoxin and digitoxin molecule]. Kasahara K; Ruiz-Torres A Klin Wochenschr; 1969 Oct; 47(20):1109-11. PubMed ID: 5381993 [No Abstract] [Full Text] [Related]
37. Digitalis glycosides: mechanisms and manifestations of toxicity. Part I. Smith TW; Antman EM; Friedman PL; Blatt CM; Marsh JD Prog Cardiovasc Dis; 1984; 26(5):413-58. PubMed ID: 6371896 [No Abstract] [Full Text] [Related]
38. Drug interactions with digitalis glycosides. Binnion PF Drugs; 1978 May; 15(5):369-80. PubMed ID: 350556 [No Abstract] [Full Text] [Related]
39. Digoxin interactions. The influence of quinidine and verapamil on the pharmacokinetics and receptor binding of digitalis glycosides. Pedersen KE Acta Med Scand Suppl; 1985; 697():1-40. PubMed ID: 3863471 [No Abstract] [Full Text] [Related]
40. [Physiological, pathological and drug factors influencing blood levels and posology of cardiotonic agents]. Carlier J Rev Med Liege; 1981 Apr; 36(8):341-8. PubMed ID: 7291816 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]